Skip to content
value.today

Trefoil Therapeutics, Inc.

🇺🇸 San Diego, California, USABiotechnologyFounded 2016

Formerly Trefoil Therapeutics, LLC

Total raised
$33 M
4 rounds on record
Latest round
$5 M
Apr 2025
First round on record
Dec 2016
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Trefoil Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2025$5 MNo. 4$2 to $10 million

Trefoil Therapeutics, Inc.: Raise no. 4, Apr 2025

Investors in this round

16 investors had bought by the notice of May 7, 2025: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jonathan Mow · Executive Officer
  • Ben McGraw · Director
  • Christy Shaffer · Director
  • John Fucci · Director
  • Kseniya Simpson · Director
  • Stella Robertson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jonathan Mow, Chief Executive Officer. Newest notice filed May 7, 2025. Read the notice at the SEC.

equitySEC
Mar 2022$12 MNo. 3$10 to $50 million

Trefoil Therapeutics, Inc.: Raise no. 3, Mar 2022

Investors in this round

14 investors had bought by the notice of Mar 22, 2022: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $12 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Eveleth · Executive Officer, Director
  • Schalon Newton · Executive Officer
  • Ben McGraw · Director
  • Christy Shaffer · Director
  • Derek Yoon · Director
  • Stella Robertson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Eveleth, Ceo. Newest notice filed Mar 22, 2022. Read the notice at the SEC.

equitySEC
Jul 2019$13 MNo. 2$10 to $50 million

Trefoil Therapeutics, Inc.: Raise no. 2, Jul 2019

Investors in this round

13 investors had bought by the notice of Aug 5, 2019: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $28 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Eveleth · Executive Officer, Director
  • Schalon Newton · Executive Officer
  • Ben McGraw · Director
  • Christy Shaffer · Director
  • Derek Yoon · Director
  • Stella Robertson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Eveleth, Chief Executive Officer. Newest notice filed Aug 5, 2019 (1 amendment). Read the notice at the SEC.

equitySEC
Dec 2016$4 MNo. 1$2 to $10 million

Trefoil Therapeutics, Inc.: Raise no. 1, Dec 2016

Investors in this round

14 investors had bought by the notice of Dec 8, 2016: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Eveleth · Executive Officer, Director
  • Schalon Newton · Executive Officer
  • Christy Shaffer · Director
  • Ralph Bradshaw · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$164,000.00 in conversion of promissory notes; $3,999,999.62 in new money.”

Signed by David Eveleth, Chief Executive Officer. Newest notice filed Dec 8, 2016. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Trefoil Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (May 2025).

    SEC Form D · May 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Trefoil Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Trefoil Therapeutics, Inc.
NameRoleNamed in
Jonathan MowExecutive officerMay 2025
David EvelethExecutive officerMar 2022
Schalon NewtonExecutive officerMar 2022
Ben McGrawDirectorMay 2025
Christy ShafferDirectorMay 2025
John FucciDirectorMay 2025
Kseniya SimpsonDirectorMay 2025
Stella RobertsonDirectorMay 2025
David EvelethDirectorMar 2022
Derek YoonDirectorMar 2022
Ralph BradshawDirectorDec 2016